124 related articles for article (PubMed ID: 36200606)
1. Growth Differentiation Factor-15 as a Candidate Biomarker in Gynecologic Malignancies: A Meta-analysis.
Roy D; Modi A; Purohit P; Khokhar M; Goyal M; Sharma S; Setia P; Facciorusso A; Sharma P
Cancer Invest; 2022 Nov; 40(10):901-910. PubMed ID: 36200606
[TBL] [Abstract][Full Text] [Related]
2. Utility of GDF-15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and meta-analysis.
Liu JY; Dong XX; Lu JN; Zhang Y; Liu KF; Liu LF; E QZ; Lu XJ; Yin JY; Shen YP
FEBS Open Bio; 2019 Jan; 9(1):35-42. PubMed ID: 30652072
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of FGF-21 and GDF-15 for the diagnosis of mitochondrial disorders: A meta-analysis.
Lin Y; Ji K; Ma X; Liu S; Li W; Zhao Y; Yan C
Ann Clin Transl Neurol; 2020 Jul; 7(7):1204-1213. PubMed ID: 32585080
[TBL] [Abstract][Full Text] [Related]
4. Appraising growth differentiation factor 15 as a promising biomarker in digestive system tumors: a meta-analysis.
Wang Y; Jiang T; Jiang M; Gu S
BMC Cancer; 2019 Feb; 19(1):177. PubMed ID: 30808336
[TBL] [Abstract][Full Text] [Related]
5. Growth-differentiation factor 15 as a predictor of mortality in patients with heart failure: a meta-analysis.
Zeng X; Li L; Wen H; Bi Q
J Cardiovasc Med (Hagerstown); 2017 Feb; 18(2):53-59. PubMed ID: 27454651
[TBL] [Abstract][Full Text] [Related]
6. GDF 15--A Novel Biomarker in the Offing for Heart Failure.
George M; Jena A; Srivatsan V; Muthukumar R; Dhandapani VE
Curr Cardiol Rev; 2016; 12(1):37-46. PubMed ID: 26750722
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.
Suri A; Perumal V; Ammalli P; Suryan V; Bansal SK
Sci Rep; 2021 Aug; 11(1):17308. PubMed ID: 34453074
[TBL] [Abstract][Full Text] [Related]
8. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases.
Davis RL; Liang C; Sue CM
Neurology; 2016 May; 86(21):2010-5. PubMed ID: 27164684
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
[TBL] [Abstract][Full Text] [Related]
10. Decoy Receptor 3 (DcR3) as a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis.
Jiang M; Lin X; He R; Lin X; Liang L; Tang R; Xiong D; Wei K; Dang Y; Feng Z; Chen G
Med Sci Monit; 2016 Jun; 22():1850-7. PubMed ID: 27246752
[TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts.
Hanatani S; Izumiya Y; Takashio S; Kojima S; Yamamuro M; Araki S; Rokutanda T; Tsujita K; Yamamoto E; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Sugiyama S; Ogawa H
Heart Vessels; 2014 Mar; 29(2):231-7. PubMed ID: 23525862
[TBL] [Abstract][Full Text] [Related]
12. The role of human epididymis protein 4 as a biomarker in gynecologic malignancies.
Plotti F; Scaletta G; Terranova C; Montera R; De Cicco Nardone C; Luvero D; Rossini G; Gatti A; Schirò T; Moncelli M; Guzzo F; Angioli R
Minerva Ginecol; 2019 Feb; 71(1):36-43. PubMed ID: 30318876
[TBL] [Abstract][Full Text] [Related]
13. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNA as diagnostic biomarkers for haematological cancers: a systematic review and meta-analysis.
Drokow EK; Sun K; Ahmed HAW; Akpabla GS; Song J; Shi M
Cancer Manag Res; 2019; 11():4313-4326. PubMed ID: 31190996
[No Abstract] [Full Text] [Related]
15. Growth differentiation factor-15 as biomarker in uterine sarcomas.
Trovik J; Salvesen HB; Cuppens T; Amant F; Staff AC
Int J Gynecol Cancer; 2014 Feb; 24(2):252-9. PubMed ID: 24401984
[TBL] [Abstract][Full Text] [Related]
16. Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders.
Peñas A; Fernández-De la Torre M; Laine-Menéndez S; Lora D; Illescas M; García-Bartolomé A; Morales-Conejo M; Arenas J; Martín MA; Morán M; Domínguez-González C; Ugalde C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203775
[TBL] [Abstract][Full Text] [Related]
17. Growth differentiation factor-15 may be a novel biomarker in pancreatic cancer: A review.
Guo M; Zhao H
Medicine (Baltimore); 2024 Feb; 103(6):e36594. PubMed ID: 38335385
[TBL] [Abstract][Full Text] [Related]
18. Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.
Myhre PL; Prebensen C; Strand H; Røysland R; Jonassen CM; Rangberg A; Sørensen V; Søvik S; Røsjø H; Svensson M; Berdal JE; Omland T
Circulation; 2020 Dec; 142(22):2128-2137. PubMed ID: 33058695
[TBL] [Abstract][Full Text] [Related]
19. Association between Plasma Levels of Growth Differentiation Factor-15 and Renal Function in the Elderly: Korean Frailty and Aging Cohort Study.
Kim JS; Kim S; Won CW; Jeong KH
Kidney Blood Press Res; 2019; 44(3):405-414. PubMed ID: 31163432
[TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer.
Staff AC; Bock AJ; Becker C; Kempf T; Wollert KC; Davidson B
Gynecol Oncol; 2010 Sep; 118(3):237-43. PubMed ID: 20576287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
